The psychoactive effect of a drug usually refers to a chemical agent that exerts an action upon the central nervous system (CNS), alters brain function, and, consequently, produces a temporary change in an individual’s mood, feelings, perception, and/or behavior. Such agents may be prescribed as therapeutic medications or used (or abused) as recreational drugs. In each case, the subjective effects produced by such agents are generally not accessible to independent verification by an observer. However, methods were developed about 50 years ago whereby human subjects could self-rate their experiences on questionnaires after administration of a drug [1]. Generally, these self-inventories require subjects to provide information about themselves and are considered valuable because they venture “below the surface” to glean the effect of a drug on an individual. Also, they are convenient because they (usually) do not require the services of a group of raters or interviewers. Their chief disadvantage may be that individuals might not completely understand the effect of the drug or their drug “experience” and therefore might not always give an accurate report. The drug discrimination (DD) paradigm is an assay of, and relates to, the subjective effect of drugs in nonhuman animals or humans. In a typical DD experiment, there are four basic components: (1) the subject, (2) the dose of drug that exerts an effect on the subject and precedes a response by the subject, (3) an appropriate (or correct) response, and (4) presentation of reinforcement. SUBJECT → DOSE OF DRUG → RESPONSE → REINFORCEMENT The drug effect that “leads to” a behavioral event (i.e., particular response) and signals that reinforcement is available is called the discriminative stimulus. A wide variety of psychoactive drugs can serve as discriminative stimuli (see below). In laboratory subjects, discriminative control by (usually) two treatments is established through the use of reinforcement (reward). When subjects receive a dose of a drug, it functions as a signal that prompts a correct behavioral response and results in the presentation of a reward. In other words, the effect of the drug is used as a “help” or “aid” to control appropriate behavioral responding by signaling that reinforcement is (or will be) available. Subjects are usually trained to distinguish administration of a particular dose of a particular drug (i.e., the training dose of a training drug) from administration of saline vehicle (i.e., usually a 0.9% sodium chloride solution that is often used as a solvent for many parenterally administered drugs). In a subject’s course of training sessions, the dose of drug is administered (i.e., drug sessions) and lever presses on the drug-designated lever (for that subject) produce reinforcement. In other training sessions, saline is administered (i.e., vehicle sessions) and responses on the (alternate) saline-designated lever produce reinforcement. The DD procedure can be characterized as a highly sensitive and very specific drug detection method that provides both quantitative and qualitative data on the effect of a training drug in relation to the effect of a test (i.e., challenge) agent. Historically, DD studies are linked by a common requirement that subjects must perform an appropriate (or correct) response that indicates a distinction was made between drug and nondrug conditions. As such, when employed with animals or humans, a subject’s response permits an experimenter to determine if a drug effect has been “perceived.” An excellent source of information on DD studies can be found at the Drug Discrimination Bibliography Web site (http://www.dd-database.org). The Web site, established and maintained by Drs. Ian P. Stolerman and Jonathan B. Kamien, is funded by the National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH) and contains close to 4000 DD references published between 1951 and the present. The citations include DD abstracts, journal articles, reviews, book chapters, and books. In addition, the Web site can be navigated to selectively retrieve references on particular training drugs, drug classes, test drugs, authors, and DD methodologies.
药物的精神活性作用通常是指一种化学制剂,它作用于中枢神经系统(CNS),改变脑功能,进而在个体的情绪、感觉、认知和/或行为上产生暂时变化。这类制剂既可以作为治疗药物开具处方,也可以作为消遣性药物被使用(或滥用)。在每种情况下,这类制剂产生的主观效应通常无法由观察者独立验证。然而,大约50年前开发出了一些方法,通过这些方法,人类受试者在服用药物后可以在问卷上对自己的体验进行自我评分[1]。一般来说,这些自我评定量表要求受试者提供关于他们自己的信息,并且被认为是有价值的,因为它们深入“表面之下”来收集药物对个体的影响。此外,它们很方便,因为(通常)不需要一组评分者或访谈者的服务。它们的主要缺点可能是个体可能不完全理解药物的作用或他们的药物“体验”,因此可能并不总是给出准确的报告。药物辨别(DD)范式是一种检测非人类动物或人类药物主观效应的分析方法。在一个典型的DD实验中,有四个基本组成部分:(1)受试者,(2)对受试者产生作用并先于受试者做出反应的药物剂量,(3)适当(或正确)的反应,以及(4)强化物的呈现。受试者→药物剂量→反应→强化物 导致行为事件(即特定反应)并表明有强化物可用的药物效应被称为辨别性刺激。多种精神活性药物都可以作为辨别性刺激(见下文)。在实验对象中,通过使用强化物(奖励)建立(通常)两种处理的辨别性控制。当受试者接受一剂药物时,它起到一个信号的作用,促使正确的行为反应并导致奖励的呈现。换句话说,药物效应被用作一种“帮助”或“辅助”,通过表明强化物可用(或将会可用)来控制适当的行为反应。受试者通常被训练区分给予特定剂量的特定药物(即训练药物的训练剂量)和给予生理盐水载体(即通常是0.9%的氯化钠溶液,常用于许多胃肠外给药的溶剂)。在受试者的训练过程中,给予药物(即药物试验),在药物指定的杠杆上按压(针对该受试者)会产生强化物。在其他训练过程中,给予生理盐水(即载体试验),在(交替的)生理盐水指定的杠杆上的反应会产生强化物。DD程序可以被描述为一种高度敏感且非常特异的药物检测方法,它提供了关于训练药物与测试(即挑战)剂效应相关的定量和定性数据。从历史上看,DD研究有一个共同要求,即受试者必须做出适当(或正确)的反应,以表明在药物和非药物条件之间做出了区分。因此,当用于动物或人类时,受试者的反应使实验者能够确定是否“感知”到了药物效应。关于DD研究的优秀信息来源可以在药物辨别文献网站(http://www.dd - database.org)上找到。该网站由伊恩·P·斯托勒曼博士和乔纳森·B·卡米恩博士建立和维护,由美国国立卫生研究院(NIH)的国家药物滥用研究所(NIDA)资助,包含了1951年至今发表的近4000篇DD参考文献。这些引用包括DD摘要、期刊文章、综述、书籍章节和书籍。此外,可以通过该网站有选择地检索关于特定训练药物、药物类别、测试药物、作者和DD方法的参考文献。